| Title | AI in Precision Medicine Market worth $3.92 billion by 2030 |
|---|
| URL | https://www.prnewswire.com/news-releases/ai-in-precision-medicine-market-to-hit-us-3-92-billion-by-2030-with-30-7-cagr--marketsandmarkets-302319510.html |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | AI in Precision Medicine Market |
|---|
| Meta Description | AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP) Global Forecast to 2030 |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| The global AI in precision medicine market is projected to reach USD 3.92 billion by 2030 from USD 0.78 billion in 2024, at a CAGR of 30.7% from 2024 to 2030. The major factors driving the growth of the AI in precision medicine market include rapidly increasing need for more customized treatments, improvement in genomics and multi-omics technologies, and a drive to accelerate drug development is driving advances in AI in precision medicine. The ability of AI to analyse such complex biological and clinical data thus allows quicker identification of mechanisms for the disease as well as tailored therapies. Additionally, factors such as increasing costs of healthcare and failures of traditional approaches pave the way for embracing AI in an aim to optimize diagnostic procedures, advance the methodologies of treatment, and elevate patient outcomes. |
